The results of these analyses revealed statistically significant positive correlations between the percentage of MM cells in the BMBs, the expression of both JAG1 and JAG2, and the activation of NOTCH signaling in myeloma (HES6 MM) as well as in non-myeloma cells (HES6 NM). The gene discussed is JAG2; the disease is Miyoshi myopathy.